Clinical Research Award
Funds ambitious experimental and early-phase clinical research to advance new treatments for dementia, supporting translational studies that bridge biological discovery and clinical intervention.
Funder: Alzheimer's Research UK
Due Dates: Rolling (EOI) | February & July (Full application outcomes)
Funding Amounts: Flexible; amount and duration depend on proposal. No set upper/lower limit.
Summary: Supports ambitious investigator-led experimental and clinical research to advance therapeutic interventions for dementia, with a focus on early-phase trials and translational studies.
Key Information: Lead or Joint Lead Applicant must be UK-based; EOIs accepted year-round; collaboration with international and industry partners encouraged.
Description
This award from Alzheimer's Research UK funds investigator-led experimental and clinical research projects aimed at accelerating the development of treatments and preventative interventions for dementia. It is designed to support studies that generate crucial biological and clinical evidence to move promising therapies toward larger-scale trials and real-world application. Eligible projects include early-phase (1b/2a) clinical trials, experimental medicine studies, and sub-studies that add value to ongoing clinical trials. The scheme promotes integration of biological investigation with clinical intervention, encourages data sharing, and fosters collaboration across academia, clinical practice, industry, and patient communities.
